NCT02480049View on ClinicalTrials.gov

A Bioequivalence Study of Montelukast From Asmakast 10mg Tabs (Sandoz, Egypt) & Singulair 10mg Tabs (Merck)

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Healthy

Interventions

DRUG

Asmakast

1 tablet contains 10 mg of montelukast

DRUG

Singulair

1 tablet contains 10 mg of montelukast

Trial Locations (1)

Unknown

Genuine Research Center GRC, Cairo

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sandoz

INDUSTRY

lead

Genuine Research Center, Egypt

INDUSTRY